Conclusion: Despite increasing patient baseline risk, perioperative mortality has declined significantly over the past 50 years, with the greatest decline in developed countries. Global priority should be given to reducing total perioperative and anaesthetic-related mortality by evidence-based best practice in developing countries.
PubMed 22998717 ↗Epicor
The short answer. There isn't much data on Epicor yet — 31 mentions, 7 with a clear outcome — so treat these numbers as anecdotal. It is most often used for immunity: 100% of 6 reports say that improved. There is a moderate body of research — 5 meta-analyses and 7 trials.
From 31 mentions in total — the rest didn't say how it went and aren't counted.
What Epicor does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found. 5 meta-analyses on PubMed ↗ · 7 randomized trials ↗
Conclusion: Current data from nonrandomized studies suggest that TEVAR may reduce early death, paraplegia, renal insufficiency, transfusions, reoperation for bleeding, cardiac complications, pneumonia, and length of stay compared with open surgery. Sustained benefits on survival have not been proven.
PubMed 20137879 ↗Conclusion: The GRACE and CAMI risk prediction models demonstrate good accuracy for evaluating the death risk of ACS patients. The accuracy of the TIMI risk prediction model is similar to that of the REMS risk prediction model. The APACHE II, SYNTAX II, EPICOR, and CAMI risk prediction models also show good accuracy for estimating the risk of death in ACS patients, although further validation is needed due to limited evidence. For improved predictive accuracy and to help advance medical interventions, the author recommends that clinical medical staff use the GRACE model to predict the death risk of ACS pa
PubMed 38436608 ↗Conclusion: In patients less than 70 yr of age undergoing cardiothoracic surgery, the adjunctive use of NSAIDs with narcotic analgesia reduces 24-hr VAS pain score and narcotic requirements.
PubMed 16371609 ↗10 human trials on ClinicalTrials.gov test Epicor — 6 completed. See all on ClinicalTrials.gov ↗
- EpiCor Clinical Study on Rapid Immune Modulating Effects · Immune Surveillance · 2023
- Effects of a Yeast Fermentate (EpiCor) Supplement on Cold or Flu Symptoms in Healthy Children · Signs and Symptoms, Respiratory · 2023
- Compare Effects of EpiCor and Vitamin C to Vitamin C Alone on the Common Cold or Influenza in Healthy Children · Signs and Symptoms, Respiratory · 2019
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I add in Epicor along with my work outs for gut support makes me feel better and it also makes me breathe better.”
“Immuse, Epicor, and Yeast extract are working really awesome for me. Better than any amount of ginger, and better than any probiotic/prebiotic/enzyme blend I've tried”
“my body refuses to get sick when I have epicor, microzinc, vitamin D+K, etc. in my rotation”
“Supplement-wise, I recently started taking Epicor and I think it has had a nice impact on limiting GERD.”
Other options for immunity
Sources
- User reports: 31 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate